Q3 2024 Holdings
Filed 2024-11-15 | 53 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $256.2M | 6,570,392 | 10.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $213.4M | 12,855,194 | 8.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $182.8M | 10,109,279 | 7.3% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $179.9M | 988,460 | 7.2% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $155.5M | 5,985,347 | 6.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $126.6M | 2,416,952 | 5.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $100.5M | 879,405 | 4.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $97.4M | 3,383,950 | 3.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $95.7M | 3,760,457 | 3.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $86.2M | 1,754,834 | 3.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $81.7M | 8,785,284 | 3.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $75.6M | 2,832,867 | 3.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $74.0M | 2,209,189 | 3.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $52.9M | 19,391,687 | 2.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $52.2M | 1,587,527 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $46.4M | 1,044,154 | 1.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.2M | 997,455 | 1.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $44.2M | 875,667 | 1.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $42.7M | 3,687,867 | 1.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $42.5M | 4,142,855 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $35.2M | 633,715 | 1.4% |
| Savara Inc(SVRA) | COM | 805111101 | $34.6M | 8,157,385 | 1.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $29.1M | 770,000 | 1.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $27.4M | 1,485,630 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $24.7M | 7,381,090 | 1.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $21.0M | 5,097,779 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $20.9M | 1,148,591 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $19.9M | 133,333 | 0.8% |
| Hillevax Inc | COM | 43157M102 | $18.7M | 10,617,062 | 0.7% |
| Merus N V | COM | N5749R100 | $18.6M | 373,100 | 0.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $17.2M | 731,020 | 0.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $16.8M | 4,623,324 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $16.1M | 576,129 | 0.6% |
| Immatics N.v(IMTX) | SHS | N44445109 | $15.5M | 1,354,711 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $11.7M | 477,327 | 0.5% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $11.3M | 1,250,786 | 0.5% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $10.2M | 1,892,547 | 0.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $10.1M | 936,576 | 0.4% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $9.9M | 3,010,727 | 0.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.6M | 689,655 | 0.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $8.0M | 2,867,750 | 0.3% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.8M | 3,062,558 | 0.3% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $7.5M | 1,069,244 | 0.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $7.4M | 1,000,000 | 0.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.2M | 470,338 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.0M | 285,331 | 0.3% |
| Pepgen Inc(PEPG) | COM | 713317105 | $6.0M | 702,694 | 0.2% |
| Elevation Oncology Inc | COM | 28623U101 | $3.6M | 5,993,579 | 0.1% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $3.5M | 500,333 | 0.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $3.4M | 108,762 | 0.1% |